According to the new market research report "Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016 at a CAGR of 16.4% during the forecast period.
Don’t miss out on business opportunities in Non Invasive Prenatal Testing (NIPT) Market @ https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html
The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.
Browse and in-depth TOC on "Non Invasive Prenatal Testing (NIPT) Market"
110 - Tables
48 - Figures
150 - Pages
Get Sample Copy for more Professional and Technical insights @https://www.marketsandmarkets.com/PressReleases/non-invasive-prenatal-testing.asp
The NIPT market is segmented based on product, method, application, end user, and region. Based on region, the NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, France, the U.K. and Rest of Europe (RoE). In 2016, North America dominated the market, followed by Europe. Factors such as high risk of chromosomal disorders with increasing maternal age and rising government investments are driving the growth of the NIPT market in this region. However, Asia is poised to be the fastest-growing region during the forecast period. The major factors driving the growth of this market are improving healthcare infrastructure, growing per capita income, and increasing awareness programs.
On the basis of product, the market is classified into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst